 |
Canadian Asthma Prevention Institute |
Latest Studies on the Influence of Nutrition on Asthma
|
||
| The #1 Ranked Site on the Internet for Information on |
|
|||
| Asthma and the Influence of Nutritional Science. | ||||
| ||||||||||
|
|
Citations for RAINS Study
1.
Lange P. Prognosis of adult asthma. Monaldi
Arch Chest Dis 1999;54:350-352.
2. Peat JK. Prevention of asthma. Eur Respir J. 1996;9:1545-1555.
3. Masuev KA. The
effect of polyunsaturated fatty acids of the omega-3 class on the late phase of the
allergic reation in bronchial asthma patients. Ter
Arkh,1997;69:31-33.
6. Masuev KA. Ter Arkh, 1997;69:33-35.
12. Woolcock A, Int J Alt
Comp Med 1996;15:7.
19. Dr. James Braly The
Nutrition and Allergy Revolution
20.
Pritchard JB Toxic substances and cell
membrane function. Fed Proc 1979;38:2220-2225.
21. Oddy WH, et al.
Association between breast feeding and asthma in 6 year old children: findings of a
prospective cohort study. BMJ 1999;319:815-819.
22. Fan YY; Chapkin
RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998;128:1411-1414.
23. Cant A, et al.
The effect of maternal supplementation with linoleic and gamma- linolenic acids on the fat
composition and content of human milk: a placebo-controlled trial. J Nutr Sci Vitaminol 1991;37:573-579.
24. Sears B. Enter the
Zone 1995;HarperCollins:New York.
25. Edelman R. Infant
nutrition and immunity. Ann NY Acad Sci, 1990;487:232-235.
26. Colgan M. Optimum Sports Nutrition Advanced Associated
Press.
27. Colgan M.
Infants, Nutrition and Immunity. Colgan Chronicles 1997;5:4
28. Weinberg ED. Iron
and susceptibility to infectious disease. Science 1975;188:1038.
29. Bullen JJ,
Griffiths E. Iron and Infection
New York: John Wiley & Sons, 1987.
30. Weinberg ED. Iron
and susceptibility to infectious disease. Science 1974;184:952.
31. Weinberg ED. Iron
and susceptibility to infectious disease. Science 1975;188:1038. 32.
Hughes CH, et al. A
retrospective study of the relationship between childhood asthma and respiratory infection
during gestation.
Clin Exp Allergy 1999;29:1378-1381.
33. Kaufman MJ.
Comparison of the free radical-scavenging ability of captopril and ascorbic acid in an
in-vitro model of lipid oxidation. Implications for reperfusion injury and ACE inhibitor
therapy. J Pharm Pharmacol 1994;46:217-220. 34. Kankaanpaa P, et al. Dietary fatty acids and allergy. Ann Med 1999;31:282-287.
35. U.S. Department
of Agriculture. Nationwide Food Consumption Survey,
Preliminary Report No.2 Washington, DC:USDA,1980.
36. U.S. Department
of Agriculture. Food Technology 1981;35:9.
37. Selhub J, et al. J Amer
Med Assoc 1993;270:2693-2726.
38.
Goldsmith GA,
et al. Vitamin C nutrition in bronchial
asthma. Arc Int Med,1941;67:597-608.
39. Dawson W, West
GB. The nature of the antagonism of
bronchospasm in the guinea pig by ascorbic acid. Jour Pharmacy Pharmacology, 1965;17:595-596.
40. Silbert NB. Vitamin C - a critical review. Medical
Times, 1951;79:370-376.
41. Ruskin S. Sodium ascorbate in the treatment of allergic
disturbances. Am Journ Dig Dis,
1947;14:302-306. Ruskin S. The epinephrine potenticity effect of sodium
ascorbate in allergy. Eye, Ear, Nose and Throat Monthly, 1948;27:63-69.
42. Brown EA, Ruskin
S. The use of cevitaminic acid in the
symptomatic and coseasonal treatment of pllinosis. Annal Allerg, 1949;7:65-70.
43. Dawson W, et al. The nature of the antagonism of bronchospasm in
the guinea pig by ascorbic acid. Jour Pharmacy Pharmacology, 1965;17:595-596.
44. Dawson W, et al. Actions of sodium ascorbate on smooth muscle. Brit Journ Pharmacology Chemo, 1967;31:269-275.
45. Bieolory L;Gandi
R. Asthma and vitamin C. Annals
Allergy 1994;73:89-96. 46. Murray, MT. Encyclopedia of Nutritional Supplements, 1996;Prima Publishing, Rocklin, CA.
47. Johnston CS, et
al. Antihistamine effect of supplemental
ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr
1992;11:172-176.
48. Hatch GE. Asthma, inhaled oxidants, and dietary
antioxidants. Am J Clin Nutr. 1995;61S:625-630.
49. Britton JR, et
al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995;151:1383-1387.
50. Cohen HA, et al. Blocking effect of vitamin C in exercise-induced
asthma. Arch Pediatr Adolesc Med.
1997;151:367-370.
51. Soutar A, et al.
Bronchial reactivity and dietary antioxidants. Thorax 1997;52:166-170.
52.
Ness AR, et al. Vitamin C status and respiratory function. Eur J Clin
Nutr 1996;50:573-579.
53.
Hemila H. Vitamin C and common cold incidence: a review of studies with
subjects under heavy physical stress. Int J Sports
Med. 1996;17: 379-383.
54. Rozanov EM, et al.
Vitamin PP and C allowances and their correction in the treatment of bronchial
asthm patients. VoprPitan 1987;Nov-Dec:21-24.
55. Schachter EN; A Schlesinger. The attenuation of exercise-induced bronchospasm
by ascorbic acid. Ann Allergy 1982;49:146-151.
56. Miric M; Haxhiu
MA. Effect of vitamin C on exercise-induced
bronchoconstriction. Plucne Bolesti
1991;43:94-97.
57. Neuman I, et al. Prevention of exercise-induced asthma by a natural
isomer mixture of beta-carotene. Ann Allergy Asthma Immunol, 1999;82:549-553.
58. Stich HF, et al. Lancet 1984;1:1204.
59. Benner SE, et al. J Nat
Cancer Inst 1993;85:44-47.
60. Shklar G, et al. Nutr
& Cancer 1993;20:145-151.
61. Colgan M The New Nutrition - Medicine for the Millennium Apple
Publishing, Vancouver, B.C. 1995.
62. Trenga C.
American Lung Association/American Thoracic Society International Conference in San Diego.
May 1997.
63. Trenga C, et al. Sulphur dioxide sensitivity and plasma
antioxidants in adult subjects with asthma. Occup Environ Med, 1999;56:544-547.
64. Kelly FJ, et al. Altered lung antioxidant status in patients with
mild asthma. Lancet, 1999;354:482-483.
65. Powell CV, et al. Antioxidant status in asthma. Pediatr Pulmonol 1994;18:34-38.
66. Murray M. Encyclopedia
of Nutritional Supplements, Prima Publishing 1996.
67.
Kadrobova J, et al. Selenium status is decreased in patients with
intrinsic asthma. Biol Trace Elem Res, 1996;52:241-248.
68. Kelly FJ.
Gluthathione: in defence of the lung. Food Chem
Toxicol 1999;37:963-966.
69. Doelman CJ; Bast
A. Oxygen radicals in lung pathology. Free Radic
Biol Med 1990;9:381-400.
70. Pennings HJ, et
al. Changes in levels of catalase and glutathione in erythrocytes of patients with stable
asthma, treated with beclomethasone dipropionate. Eur
Respir J 1999;13:1260-1266.
71. Jain A, et al. Effect of ascorbate or N-acetylcysteine treatment
in a patient with hereditary glutathione sythetase deficiecy. J Pediatr
1994;124:229-233.
72. Johnson CJ, et
al. Vitamin C elevates red blood cell
glutathione in healthy adults. Am J Clin Nutr 1993;58:103-105.
73. Ajayi OA, et al. Clinical trial of riboflavin in sickle cell
disease. East Afr Med 1993;70:418-421.
76. Boljevic S, et
al. Changes in free radicals and possibility
of their correction in patients with bronchial asthma. Vojnosanit Pregl 1993;50:3-18.
77. Baker JC, et al. Dietary antioxidants and magnesium in type 1
brittle asthma: a case control study. Thorax, 1999;54:115-118.
78. Troisi RJ, et al. A prospective study of diet and adult-onset
asthma. Am J Respir Crit Care Med, 1995:151:1401-1408.
79. Simon SW. Vitamin B12 therapy in allergy and chronic
dermatoses. J Allergy 1951;2:183-185.
80. Anibarro B, et
al. Asthma with sulfite intolerance in children: a blocking study with cyanocobalamin. J Allergy Clin Immunol 1992;90:103-109.
81. Murray M. Encyclopedia of Nutritional Supplements Prima Publishing, 1996.
82. Lakshmanan FL, et
al. Magnesium intakes, balances, and blood levels of adults consuming self- selected
diets. Am J Clin Nutr 1984;40(Supp):1380-1389.
83. Morgan KJ;
Stampley GL. Dietary intake levels and food sources of magnesium and calcium for selected
segments of the US population. Magnesium 1988;7:225-233.
85. Fantidis P, et
al. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma
between attacks. J R Soc Med 1995;88:441-445.
86. Hill JM; Britton
J. Effect of intravenous magnesium sulphate on airway calibre and airway reactivity to
histamine in asthmatic subjects. Br J Clin
Pharmacol 1996;42:629-631.
87. Okayama H, et al.
Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA 1987;257:1076-1078.
88. Okayama H, et al.
Treatment of status asthmaticus with intravenous magnesium sulfate. J Asthma 1991;28:11-17.
89. Skobeloff EM, et
al. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency
department. JAMA 1989;262:1210-1213.
90. Skobeloff EM, et
al. Magnesium sulfate for the treatment of bronchospasm complicating acute bronchitis in a
four-months'-pregnant woman. Ann Emerg Med
1993;22:1365-1367.
91. McNamara RM, et
al. Intravenous magnesium sulfate in the management of acute respiratory failure
complicating asthma. Ann Emerg Med
1989;18:197-199.
92. Kuitert LM;
Kletchko SL. Intravenous magnesium sulfate in acute, life-threatening asthma
93. Noppen M, et al.
Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 1990;97:373-376.
94. Hauser SP, et al.
Intravenous magnesium administration in bronchial asthma. Schweiz Med Wochenschr 1989;119:1633-1635.
95. Fox CH, et al. An investigation of hypomagnesemia among
ambulatory African Americans. J Fam Pract 1999;48:636-639.
96. Fesmire FM. Intravenous magnesium for acute asthma. Ann Emerg Med 1993;22:616-617; discussion 618-619.
97. Skobeloff EM;
McNamara RM. Intravenous magnesium for
acute asthma. Ann Emerg Med 1993;22:617-618;
discussion 618-619.
98. Shiekh S, et al.
Gastroesophageal reflux in infants with wheezing. Pediatr Pulmonol
1999;28:181-186.
99. Palombini BC, et
al. A pathogenic triad in chronic cough - Asthma, postnasal drip syndrome, and
gastroesophageal reflux disease.
CHEST
1999;116:279-284.
100.Laparra, J., J.
Michaud, and J. Masquelier. Plantes Medicinales et Phytotherapie, Tome XI:133-142, 1977.
101. Indena S.p.A.,
Internal Report (Data on file) GET STUDY
102. D’Alonzo
GE, et al. Chronobiol Int 1999
103. Harding SM
Chronobiol Int, 1999
104. Chakrabarti S,
et al. Airway response to acid instillation in esophagus in bronchial asthma. Indian J Gastroenterol 1995;14:44-47.
105. Middleton E,
Drzewieki G. Flavonoid inhibition of human
basophil histamine release stimulated by various agents.
Biochem Pharmacol,1984;33:3333-3338. 106. Middleton E Jr; Drzewiecki. Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem Pharmacol 1982;31:1449-1453. 107. Middleton E Jr; Drzewiecki. Naturally occurring flavonoids and human basophil histamine release. Int Arch Allergy Appl Immunol 1985;77:155-157.
108. Kakegawa H, et
al. Chem
Pharm. Bull 1985;33:5079.
109. Vela SM, et al.
Inhibition of gastric acid secretion by the aqueous extract and purified extracts of
Stachytarpheta cayennensis. Planta Med
1997;63:36-39.
110. Beil W, et al. Effects of flavonoids on parietal cell acid
secretion, gastric mucosal prostaglandin production and Helicobacter pylori growth. Arzneimittelforschung 1995;45:697-700.
111. Friesenecker B,
et al. Cellular basis of inflammation, edema
and the activity of Daflon 500 mg. Int J
Microcirc Clin Exp 1995;15 Suppl 1:17-21.
112. Emim JA
Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid,
hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J Pharm Pharmacol 1994;46:118-122.
113. Borissova P, et
al. Antiinflammatory effect of flavonoids in
the natural juice from Aronia melanocarpa, rutin and rutin-magnesium complex on an
experimental model of inflammation induced by histamine and serotonin. Acta Physiol Pharmacol Bulg 1994;20:25-30.
114. Jaffar ZH;
Pearce FL. Some characteristics of the ATP-induced histamine release from and
permeabilization of rat mast cells. Agents
Actions 1993;40:18-27.
115. Wu JB, et al.
Biologically active constituents of Centipeda minima: sesquiterpenes of potential
anti-allergy activity. Chem Pharm Bull (Tokyo) 1991;39:3272-3275.
116. Simoes CM, et
al. Pharmacological investigations on Achyrocline satureioides.
117. Fanning MJ, et
al. Quercetin inhibits anaphylactic contraction of guinea pig ileum smooth muscle. Int Arch
Allergy Appl Immunol 1983;71:371-373. 118. Pearce FL, et al. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol 1984;73:819-823.
119. Sasajima M, et
al. Studies on the anti-ulcer effects of isoprenyl flavonoids (1). The anti-ulcer effects
of isoprenyl chalcone extracted from Sophora subprostrata. Nippon
Yakurigaku Zasshi 1978;74:897-905.
120. Lambev I, et
al. Flavonoids with antioxidant action
(naringin and rutin) and the release of mastocytic and nonmastocytic histamine. Acta Physiol Pharmacol Bulg 1980;6:70-75.
121. Tarayre JP;
Lauressergues H. Advantages of a combination of proteolytic enzymes, flavonoids and
ascorbic acid in comparison with non-steroid anti-inflammatory agents. Arzneimittelforschung 1977;27:1144-1149.
122. Maggi E. The TH1/TH2 paradigm in allergy. Immunotechnology, 1998;3:233-244.
123. Sprietsma JE Modern diets and diseases: NO-zinc balance. Under
Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS,
autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and
cancer. Med Hypotheses 1999;53:6-16.
124. Pearlman DS. Pathophysiology of the inflammatory
response. J Allergy Clin Immunol,
1999;104:132-137.
125. Taburet AM;
Schmit B. Pharmacokinetic optimisation of
asthma treatment. Clin Pharmacokinet
1994;26:396-418.
126. Pearlman DS. Antihistamines: pharmacology and clinical use. Drugs 1976;12:258-273.
127. Przybylowski J,
et al. Studies on serum gastrin concentrations after test meal stimulation in patients
suffering from bronchial asthma. Allergol
Immunopathol (Madr) 1989;17:301-306.
128. Beisel W, et
al. Single-nutrient effects of immunologic functions. JAMA 1981;245:53-58.
129. Collip PJ, et
al. Pyridoxine treatment of childhood asthma.
Ann Allergy
1975;35:93-97.
130. Murray, M.
Encyclopedia of Nutritional Supplements, Prima Publishing, 1996. 130 A. Reynolds RD;Natta CL. Depressed plasma pyridoxal-5-phosphate concentrations in adult asthmatics. Am J Clin Nutr 1985;41:684-688.
131. Delport R., et
al. Vitamin B6 nutritional status in asthma: the effect of theophylline therapy on plasma
pyridoxal-5'-phosphate and pyridoxal levels. Int J
Vitam Nutr Res 1988;58:67-72.
132. Shimizu T, et
al. Relation between theophylline and circulating vitamin levels in children with asthma. Pharmacology 1996;53:384-389.
133. Shimizu T, et
al. Theophylline attenuates circulating vitamin B6 levels in children with asthma. Pharmacology 1994;49:392-397.
134. Balabolkin II,
et al. Use of vitamins in allergic illnesses in children. Vopr Med Khim 1992;38:36-40.
135. Ubbink JB, et
al. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 1996;98:177-184.
136. Glenn GM, et
al. Pyridoxine as therapy in theophylline-induced seizures. Vet Hum Toxicol 1995;37:342-345.
137. Joseph KS, et
al. Increased morbidity and mortality related to asthma among asthmatic patients who use
major tranquillisers. BMJ 1996;312:79-82.
138. Carmago, CA Jr.
Et al. Prospective study of body mass index,
weight change, and risk of adult- onset asthma in women. Arch Intern Med 1999;159:2582-2588.
139. Wilson M..
Arch Intern Med
1999;159:2513-2514,2582-2588
140.
Osborne ML,
et al. Characteristics of patients with asthma within a large HMO: a comparison by age and
gender.
Am J Respir Crit Care Med
,1998;157:123-128.
141. Colgan M.
142. Mazolewski P, et al.
The impact of nutritional status on the outcome of lung volume reduction surgery -
a prospective study. Chest
1999;116:693-696.
143. Zheng LM;Wang
JZ. Iatrogenic osteoporosis: six case
reports. Chung Hua Nei Ko Tsa Chih 1994;33:658-660.
144. Worth H, et al. Therapy of steroid-induced bone loss in adult
asthmatics with calcium, vitamin D, and a diphophonate.
Am J Respir Crit Care Med 1994;150:394-397.
145. National
Research Council, Recommended Dietary Allowances, 10th Edition, National
Academy Press, Washington, DC, 1989.
146. Mitchell JA;
Warner TD. Cyclo-oxygenase-2: pharmacology,
physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999;128:1121-1132. 147. Cryer B, et al. Effects of cutaneous aspirin on the human stomach and duodenum. Proc Assoc Am Physicians 1999;111:448-56
148. Cryer B;
Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal,
and rectal prostaglandin levels and on mucosal injury in healthy humans.
Gastroenterology
1999;117:17-25.
149. Wu D, et al. Age-associated increase in PGE2 synthesis and COX
activity in murine macrophages is reversed by vitamin E.
Am J Physiol 1998;275:C661-C668.
150. Yano T, et al. The modulation effect of vitamin E on
prostaglandin E2 level and ornithine decarboxylase activity at the promotion phase of lung
tumorigenesis in mice. Biochem Pharmacol 1997;53:1757-1759.
151. Wander RC, et
al. The ratio of dietary (n-6) to (n-3) fatty
acids influences immune system function, eicosanoid metabolism, lipid peroxidation and
vitamin E status in aged dogs. J Nutr 1997;127:1198-1205.
152. Beharka, AA, et al. Macrophage prostaglandin production contributes to
the age-associated decrease in T cell function which is reversed by the dietary
antioxidant vitamin E. Mech Ageing Dev 1997;93:59-77.
153. Jeng KC, et al. Supplementation with vitamins C and E enhances
cytokine production by peripheral blood mononuclear cells in healthy adults. Am J
Clin Nutr 1996;960-965.
154. Demers LM; Kuhn
DC. Influence of mineral dusts on metabolism
of arachidonic acid by alvolar macrophage. Environ Health Perspect 1994;102:97-100.
155. Romach EH, et
al. Effects of RRR-alpha-tocopheryl succinate
on IL-1 and PGE2 production by macrophages. Nutr Cancer 1993;20:205-214.
156. Sakamoto W, et
al. Inhibition of PGE2 production in
macrophages from vitamin E-treated rats. Prostaglandins Leukot Essent Fatty Acids 1991;44:89-92.
157. Meydani SN, et
al. Oral (n-3) fatty acid supplementation
suppresses cytokine production and lymphocyte proliferation: comparison between young and
older women. J Nutr 1991;121:547-555.
158. Meydani SN, et
al. Vitamin E supplementation enhances
cell-mediated immunity in healthy elderly subjects. Am
J Clin Nutr 1991;53:976-977.
159. Erasmus, U Fats that
Heal, Fats that Kill 1993, Alive Books,
Vancouver, B.C.
160. Emory T. Iron and Your Health: Facts and Fallacies Boca Raton, FL: CRC Press, 1991
161. Goldstein MF,
et al. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive
lung disease. Chest 1999;116:1733-1749.
162. Kobayashi T, et
al. Curcumin inhibition of Dermatophagoides
farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor
(GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem
Pharmacol 1997;54:819-824.
163. Galati EM, et
al. Biological effects of hesperidin, a
citrus flavonoid. Framaco 1994;40:709712.
164. Jean T;
Bodinier MC. Mediators involved in
inflammation: effects of Daflon 500 mg on their release.
Angiology
1994;45:554-559.
165. Bourgoin BP, et
al. Lead content in 70 brands of dietary
calcium supplements. Am J Public Health
1993;83:1155-1160.
166. Murray M,
Encyclopedia of Nutritional Supplements, Prima Publishing, 1996.
166A. Horwitt MK,
Vitamin E: A re-examination. Am J Clin Nutr 1976;29:569-578.
167. Ingold KU, et
al. Biokinetics of and discrimination between
dietary RRR- and SRRR- alphatocopherols in the male rat.
Lipids 1987;22:163-172.
168. Burton GW;
Traber MG. Vitamin E: Antioxidant activity,
biokinetics, and bioavailability. Annu Rev Nutr
1992;10:357-382.
169. Ekstrom T;
Tibbling L. Gastro-oesophageal reflux and nocturnal asthma. Eur Respir J 1988;1:636-638.
170. Casillas AM, et
al. Enhancement of allergic inflammation by diesel exhaust particles:permissive role of
reactive oxygen species. Ann Allergy Asthma
Immunol 1999;83:624-629.
170A. Sheppard L, et
al. Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle,
Washington, 1987-1994. Epidemiology 1999;1:23-30.
171. Norris G, et
al. An association between fine particles and asthma emergency department visits for
children in Seattle. Environ Health Perspect
1999;107:489-493.
172. 173. Adam O, et al. Low fat diet decreases alpha-tocopherol levels, and stimulates LDL oxidation and eicosanoid biosynthesis in man. Eur J Med Res, 1995;1:65-71. 174. Suzuki, Y.J., M. Tsuchiya, and L. Packer. 1991. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Rad. Res. Commun., 15: 255-263 175. Packer, L., E.H. Witt, and H.J. Tritschler. 1996. Antioxidant properties and clinical applications of alpha-lipoic acid and dihydrolipoic acid. Pp. 545-591. In. E. Cadenas and L. Packer (eds). Handbook of Antioxidants. Marcel Dekker, Inc., New York. 176. Podda, M., H.J. Tritschler, H. Hlrich, and L. Packer. 1994. a -lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem. Biophys. Res. Commun., 204: 98-104. 177. Sigel, H. and B. Prijs. 1978. Stability of binary and ternary complexes of a -lipoate and lipoate derivatives with Mn 2+, Cu2+, and Zn2+ in solution. Arch. Biochem Biophys. 187: 208-214. 178. Ou, P., H.J. Tritschler, and S.P. Wolff. 1995. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem. Pharmacol., 50: 123-126. 179. Packer, L., E.H. Witt, and H.J. Tritschler. 1996. Antioxidant properties and clinical applications of alpha-lipoic acid and dihydrolipoic acid. In. E. Cadenas and L. Packer (eds). Handbook of Antioxidants. Marcel Dekker, Inc., New York. p 562-4. 180. Packer, L., E.H. Witt, and H.J. Tritschler. 1996. Antioxidant properties and clinical applications of alpha-lipoic acid and dihydrolipoic acid. In. E. Cadenas and L. Packer (eds). Handbook of Antioxidants. Marcel Dekker, Inc., New York. p 566-81. 181. © 1997, USANA, Inc. All rights reserved. 182. Cook NC and S Samman. Flavonoids - chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 7:66-76. (1996) 183. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. Wld Rev Nutr. Diet. 24:117-191. (1976) 184. Hanasaki Y, S Ogawa, and S Fukui. The correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16:845-50. (1994) 185. Hope WC, Welton AF, Fiedler-Nagy C, Batula-Bernardo C, Coffey JW. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol 32:367-71. (1983) 186. Duarte J, Perez Vizcaino F, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Parmacol 24:857-62. (1993) 187. Ratty AK and NP Das. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationships. Biochem Med Metab Biol 39:69-79. (1988) 188. Cavallini L, Bindoli A, Siliprandi N. Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. Pharmacol Res Commun 10:133-6. (1978) 189. Vinson JA et al. Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agri Food Chem 43:2800-2. (1995) 190. Hertog MGL, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 349:699 (1997) 191. Hertog MGL, et al. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40:2379-83. (1992) 192. Ho CT, et al (eds). Food Phytochemicals and Cancer Prevention. ACS Symposium Series 547. American Chemical Assoc., Washington DC. (1994) 193. Block G. The data support a role for antioxidants in reducing cancer risk. Nutr Rev 50:207-13. (1992) 194. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol and Med 20:933-56. (1996) 195. Krebs-Smith SM, Cook A, Subar AF, Cleveland L, Friday J. US adults’ fruit and vegetable intakes, 1989-1991: a revised baseline for the Healthy People 2000 objective. Am J Public Health 85:1623-9. (1995). 196. Krebs-Smith SM, Cook A, Subar AF, Cleveland L, Friday J, Kahle LL. Fruit and vegetable intake so children and adolescents in the United States. Arch Pediatr Adolesc Med 150:81-6. (1996) 197. Hertog MGL, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 20:21-9. (1993) 198. Fantidis P, Ruic J, Marin M et al., Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. J R Soc Med 1995 Aug; 88(8):441-5. 199. Muir KW, Lees KR. A randomized double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke 1995 Jul ;26(7)1183-8. 200. Cathely PA, Yoganathan T, Komer C, Kelly M. Magnesium and arrhythmias affect coronary artery bypass surgery. J Cariothorac Vasc Anesth 1994 Apr; 8(2):188-91. 201. Shakerinia T, Ali IM, Sullivan JA. Ca J Surg. 1996 Oct 39(5):397-400. 202. Mauskop A, Altura BT, Craco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci (Colch) 1995 Dec; 89(6):633-6. 203. Mazzzotta G, Sarchielli P. Headache. 1996 Jun ;36(6):357-61. 204. Satake K, Lee JD, Shimizu H, Ueda T, Nakamura T. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. J Am Coll Cardiol. 1996 Oct; 28(4):897-902. 205. Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 1995 Jul;173(1):175-80. 206. Ziegler, E, Filer L. Present Knowledge in Nutrition 7th Edition. Washington DC: ILSI Press; 1996. 207. Pointillart A, Denis I, Colin C. Effects of dietary vitamin D on magnesium absorption and bone mineral contents in pigs on normal magnesium intakes. Mangnes Res. 1995 Mar; 8(1):19-26. 208. Ohta A, Ohtsuki M, Baba S, Adachi T, Sakata T, Sakaguchi E. Calcium and magnesium absorption from the colon and rectum are increased in rats fed fructooligosaccharides. J Nutr 1995 Sep; 125(9):2417-24. 209. Mock, DM. Biotin. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington (DC):International Life Sciences Institute. 1996. p 220. 210. Mock, DM. Biotin. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington (DC):International Life Sciences Institute. 1996. P 227. 211 Mock, DM. Biotin. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington (DC):International Life Sciences Institute. 1996. p 225. 212. Mock, DM. Biotin. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington (DC):International Life Sciences Institute. 1996. p 228. 213. Cohen RD, and Braunstein, NS. Vitasearch. Great Bay Nutrtiion Resources, Newmarket, NH. 49 pp. 214. Mock, DM. Biotin. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington (DC):International Life Sciences Institute. 1996. p 232. 215. Groff JL, Gropper SS, Hunt SM. Advanced Nutrition and Human Metabolism. New York:West Publishing Co. 1995. 575 pp. 216. Olson JA. Vitamin A. In Ziegler EE, Filer LJ. Present Knowledge in Nutrition. Washinton (DC):ILSI Press. 1996. p 109-19. 217. Handelman GJ. Carotenoids as scavengers of active oxygen species. In Cadenas E, Packer L (eds). Handbook of Antioxidants. New York: Marcel Dekker, Inc. 1996. p 259-314. 218.National Research Council. Recommended Dietary Allowances. Washington (DC): National Academy Press. 1989. 284 pp. 219.Swanson JE, Parker RS. Biological effects of carotenoids in humans. In Cadenas E, Packer L (eds). Handbook of Antioxidants. New York: Marcel Dekker, Inc. 1996. p 337-70. 220. Khachik F. Carotenoids in fruits, vegetables, and human blood and their role in nutritional prevention of cancer, heart disease, and cataract. Nutrient Composition Laboratory, BHNRC, ARS, USDA. 1995 221. Juniper EF, et al. How to develop and validate a new health-related quality of life instrument. In Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippencott-Raven Publishers, Philadelphia, 1996;49-56 222. Guyatt GH, et al. Measuring health status; what are the necessary measurement properties? J Clin Epidemiol 1992;45:1341-1345 223. Juniper EF, et al. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83. 224. Juniper EF, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993 225. Juniper EF, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-87. 226. Recker R. Calcium absorption and achlorhydria. N Engl J Med 1985;313:70-73. 227. Murray, M. Encyclopedia of Nutritional Supplements. Prima Publishing, Rocklin CA. 1996:151-152. 228. Zitt MJ.The role of nonsedating antihistamines in asthma therapy. Allergy Asthma Proc. 2003 Jul-Aug;24(4):239-52. Department of Medicine, Division of Allergy and Immunology, State University of New York at Stony Brook, Stony Brook, New York, USA. 229. Mortimer KJ, Harrison TW, Tattersfield AE., Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol. 2005 Jan;94(1):15-21; quiz 22-3, 79. 230. Litonjua AA, Weiss ST Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007 Nov;120(5):1031-5. Epub 2007 Oct 24. 231. Riccioni G, Bucciarelli T, Mancini B, Di Ilio C, Della Vecchia R, D'Orazio N. Plasma lycopene and antioxidant vitamins in asthma: the PLAVA study. J Asthma. 2007 Jul-Aug;44(6):429-32. 232. Zingg JM.Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland. Vitamin E and mast cells. Vitam Horm. 2007;76:393-418 233. Devereux G. Early life events in asthma--diet. Pediatr Pulmonol. 2007 Aug;42(8):663-73 234. Burns JS, Dockery DW, Neas LM, Schwartz J, Coull BA, Raizenne M, Speizer FE. Low dietary nutrient intakes and respiratory health in adolescents. Chest. 2007 Jul;132(1):238-45. Epub 2007 May 2 235. Grievink L, Smit HA, Ocké MC, van 't Veer P, Kromhout D Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax. 1998 Mar;53(3):166-71. 236. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct;56(8):365-79.
|
|
